Rm. Pascale et al., GENOMIC ABNORMALITIES IN HEPATOCARCINOGENESIS - IMPLICATIONS FOR A CHEMOPREVENTIVE STRATEGY, Anticancer research, 13(5A), 1993, pp. 1341-1356
Carcinogenesis is a complex process characterized by the cumulative ac
tivation of various oncogenes and the inactivation of suppressor genes
. Epigenetic mechanisms are also involved. Mutational activation of ra
s family genes occurs in most spontaneous or carcinogen-induced liver
tumors, in susceptible mice, and less frequently in preneoplastic lesi
ons. This suggests a pathogenetic role of these changes in hepatic car
cinogenesis, in the mouse. Overexpression of various growth-related ge
nes occurs in preneoplastic tissue during rat liver carcinogenesis, bu
t mutational activation of protooncogenes, notably of ras family genes
, seems to be a late and rare event, while c-myc amplification is a la
te but frequent event in both rodent and human carcinogenesis. However
, mutation of the suppressor p53 gene has been found in relatively ear
ly preneoplastic lesions in rat liver, and it may be frequently seen i
n human hepatocellular carcinomas. The possibility that this mutation
is involved in the initiation stage of liver carcinogenesis is an attr
active hypothesis which needs further evaluation. DNA hypomethylation
is involved in carcinogenesis, but the mechanisms underlying this effe
ct are still elusive. Hypomethylation of growth-related genes is assoc
iated with their overexpression and this could favor overgrowth of pre
neoplastic liver tissue. Decrease in S-adenosyl methionine/S-adenosylh
omocysteine (SAM/SAH) ratio occurs in the liver of rats fed a methyl d
eficient diet, which is a carcinogenic treatment, and in preneoplastic
liver tissue, developing in initiated/promoted rats fed an adequate d
iet. The role of low SAM/SAH ratio in carcinogenesis is substantiated
by the tumor chemopreventive effect of lipotropic compounds. Treatment
with exogenous SAM prevents the development of preneoplastic and neop
lastic lesions in rat liver. This is associated with recovery of SAM/S
AH ratio, DNA methylation and inhibition of growth-related gene expres
sion. SAM effect on prenoplastic cell growth is abolished by 5-azacyti
dine, a hypomethylating agent, indicating the involvement of DNA methy
lation. The possibility that in SAM-treated rats, methylation and inhi
bition of the expression of growth-related genes is implicated in grow
th restraint is attractive and should be further evaluated. Modulation
of rat liver carcinogenesis by influencing gene expression through DN
A methylation or other epigenetic mechanisms could be a new approach t
o chemoprevention of these tumors.